Deep Bio

Join Deep Bio At AACR And Discover How DeepDx® Prostate Is Empowering Pathologists

Are you ready to learn about the latest breakthroughs in digital pathology? Join Deep Bio at booth #3445 and discover how DeepDx® Prostate is empowering pathologists to diagnose and treat prostate can...

Deep Bio’s Novel Study Results Reaffirm Its Global Presence

SEOUL, SOUTH KOREA (PRWEB) MARCH 14, 2023 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software shared three research abstracts at the United States and Canad...

Deep Bio and Visiopharm announce a collaborative integration of a clinical-grade AI prostate cancer solution with a leading digital pathology platform

Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for research and diagnostics, announced a strategic partners...

Deep Bio Inc. successfully integrates DeepDx® Prostate algorithm into the HALO AP® platform from Indica Labs

A CASE STUDY OF DEEPDX® PROSTATE FROM DEEP BIO DEEPDX® PROSTATE FROM DEEP BIO DeepDx® Prostate is a clinically validated and CEmarked AI-based image analysis algorithm for prostate core needle biopsy ...

Deep Bio Acquires ISO 27001 Certification for Information Security Management

Deep Bio: Enhanced security and reliability through adherence to the globally recognized information security standards SEOUL, SOUTH KOREA (PRWEB) OCTOBER 27, 2022 Deep Bio, a pioneer in medical AI fo...

Deep Bio Acquires MDSAP Certification, Paving the Way for Global Expansion

SEOUL, SOUTH KOREA (PRWEB) AUGUST 16, 2022 Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, announced that it has been recently granted Medical Device Single Audit Program (MDSAP) ...

Deep Bio successfully integrates DeepDx® Prostate algorithm into HALO AP® platform from Indica Labs

DeepDx® prostate algorithm results shown in the HALO AP® platform. Deep Bio successfully integrates DeepDx® Prostate algorithm into HALO AP® platform from Indica Labs SEOUL, South Korea and ALBUQUERQU...

Deep Bio’s AI Support for Cancer Diagnosis has been Designated as an Innovative Product by the Korean Public Procurement Service

SEOUL, SOUTH KOREA (PRWEB) JULY 25, 2022 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software, announced that its AI solution for grading the severity of prostate ca...

  • 1
  • 2